Status:
COMPLETED
VisR for Noninvasively Interrogating Stromal Collagen Organization as a Breast Cancer Biomarker: Evaluation of Compression in Control Subjects
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
30-90 years
Brief Summary
Purpose: The purpose of this study is to evaluate in vivo the diagnostic relevance of ultrasound-derived metrics for elasticity, viscosity, and anisotropy. To this end, we will investigate the effect ...
Detailed Description
The primary objective of breast cancer screening is to identify early stage cancer, or precancerous lesions, at a time before symptoms emerge and when treatment is likely to result in a cure. Screenin...
Eligibility Criteria
Inclusion
- Patients are 30-90 years of age
- Patients have received a negative result from mammogram screening in past year
- Patients have no history of breast disease
- Informed consent obtained and signed
Exclusion
- Inability to provide informed consent
- Inability to communicate in English
- Inability to remain motionless for 15 minutes
- Any pathologies of the breast or history of breast disease
- Patients who are pregnant
- Patients who are lactating
- Patients with breast implants
- Patients with implanted cardioverters or pacemakers
Key Trial Info
Start Date :
October 16 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06547034
Start Date
October 16 2024
End Date
February 28 2025
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599